Reduced Appetite in Crohn's Disease: Investigating the Role of the Gut Brain Pathways
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 2
- 主要终点
- Changes in Blood Oxygenation Level Dependent (BOLD) response in the brain following a fatty acid test meal in Crohn's patients and healthy controls
研究概览
简要总结
Crohn's disease (CD) is becoming more common, specifically in the western world. One of the main features of this disease is weight loss and malnutrition. Although clinically common, these problems are not well understood. Loss of appetite and symptoms such as tummy aches and bloating are common causes for weight loss in this group of patients. This problem has a strong negative effect on the patients' quality of life and significantly increases the cost of treating CD. Enteroendocrine cells are nutrient sensors in the bowel that relay to the brain to control food intake. Recent evidence has showed that these cells increase in number in active CD and secrete more hormones that negatively affect appetite. The increased levels of these hormones should have an overall negative effect on the brain and thus decrease food intake, bloating, symptoms of sickness. All these symptoms lead to malnutrition. These are hypotheses that require further proof. Current technological advances in magnetic resonance imaging (MRI) has enabled the mapping of changes in activity in important areas in the brain that control food intake. The involvement of the brain in control of food intake is still not fully understood. This work will be the first step in the right direction to start targeting the problems of appetite, weight loss and a poor quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 16 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 16-75 years
- •Ulceration seen at ileocolonoscopy, aiming for a simple endoscopic score for Crohn's disease (SES-CD) of 4-19, in the absence of stricturing disease or,
- •Intestinal inflammation or deep ulceration seen on CT or MR enterography, with the disease activity quantified via the MaRIA score or,
- •Faecal calprotectin of >250µg/g
- •C-Reactive protein >5mg/dl
- •Harvey-Bradshaw index score of 5-16
- •Body mass index (BMI) 18-35
- •As for HV participants, inclusion criteria 1 and 7 will apply.
排除标准
- •Malignant disease
- •BMI <18 and >35
- •Significant cardiovascular or respiratory disease
- •Diabetes mellitus
- •Current Infection
- •Neurological or cognitive impairment; significant physical disability
- •Significant hepatic disease or renal failure
- •Abnormal blood results other than those explained by CD including bleeding diatheses (apart from in the case of HV where all unexplained blood results are an exclusion criteria)
- •Subjects currently participating in (or in the last three months) any other research project
- •pregnancy or breastfeeding or
- •if MRI is contraindicated (e.g. pacemaker).
- •Severe Crohn's disease where a delay in a change in medical treatment for 23 weeks would not be clinically advisable.
- •As for healthy volunteer participants all exclusion criteria apart from no.12.
研究组 & 干预措施
Crohn's Disease
Active Crohn's Disease
干预措施: Dodecanoate acid and saline (Other)
Healthy
Healthy volunteers
干预措施: Dodecanoate acid and saline (Other)
结局指标
主要结局
Changes in Blood Oxygenation Level Dependent (BOLD) response in the brain following a fatty acid test meal in Crohn's patients and healthy controls
时间窗: 3 years
次要结局
- Changes in arterial spin labeling measures of cerebral blood flow and changes in gut peptide levels following the fatty acid test meal.(3 years)